Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-23 @ 1:15 AM
Study NCT ID:
NCT03946358
Status:
COMPLETED
Last Update Posted:
2024-12-20
First Post:
2019-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
P/2019/418
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None